Showing posts with label health. Show all posts
Showing posts with label health. Show all posts

Wednesday 29 June 2011

Obesity 'is higher among non-smoking women'

Obesity 'is higher among non-smoking women'

An overweight person walks through Glasgow City centre The study claimed non-smokers were more likely to be obese

Non-smoking woman are more likely to be obese and die of associated illnesses than those who smoke, according to research.

About 8,000 women were recruited to the Renfrew and Paisley study from 1972 to 1976. Of these, 40% had never smoked.

The authors, led by Dr Laurence Gruer from NHS Health Scotland, found 60% of non-smokers were overweight or obese compared with 40% of those who smoked.

The study claimed extra weight acted as a major contributor to premature death.

However, experts stressed that smoking was a "much stronger" risk factor than obesity.

The study of women aged 45 to 64, published in the British Medical Journal, said the highest rate of obesity among non-smokers was found in low income groups.

Almost 70% of women in this category were overweight or obese, according to the research.

Dr Gruer said: "You can certainly assume that if you are obese, you are more likely to die of things like diabetes, heart attacks and strokes."

Start Quote

It goes against the idea that if you live in a poor neighbourhood or came from a working class background, then your health will be worse, regardless”

End Quote Dr Laurence Gruer NHS Health Scotland

Researchers also suggested declining numbers of female smokers over the past few decades may have had a direct impact on obesity levels - with fewer people using cigarettes in an attempt to suppress their appetites.

The study also found that non-smokers from a lower occupational group were no more likely to die early if they lived a healthy lifestyle.

Dr Gruer said: "If you never smoke and you keep your weight within the reasonable limit then even if you earn below average income and live in a more disadvantaged area, you can still expect to live a long and healthy life.

"You are not doomed to die early just because you happen not to have a high income or good job or live in a leafy suburb.

"It goes against the idea that if you live in a poor neighbourhood or came from a working class background, then your health will be worse, regardless."

Prof Johan Mackenbach from the Erasmus Medical Centre in Rotterdam welcomed the study but added: "It is important not to forget that smoking is a much stronger risk factor for mortality than most other risk factors, including obesity."

More on This Story

The BBC is not responsible for the content of external Internet sites

Wednesday 22 June 2011

pasty faced wimp Dr Mark Salter of the Health Protection Agency.

Health warning to festival goers

Glastonbury festival, 2010 Crowds create infection risks

Related Stories

Too much alcohol, drugs, and sex, coupled with poor hygiene, can be a health risk at festivals, an expert is warning.

Sunburn, heat stroke, sprains and other minor ailments make up most casualties at music events, says Dr Mark Salter of the Health Protection Agency.

But there are occasional reports of sexual health problems, heart attacks and chest complaints.

Avoiding doing anything to excess is the best way to stay healthy, he adds.

Dr Salter, a consultant in communicable disease control at the HPA's Health Protection Unit in the South West has been attending festivals, including Glastonbury, for 20 years, to offer health protection advice.

More top tips for festival health

  • Anyone who is unwell before a festival, particularly with diarrhoea and sickness, should not go to prevent spreading infection
  • Take a good supply of existing medicines and pack them in luggage
  • Find out where health services are at the festival, and seek help if you fall ill
  • Drinking water should be taken from potable water taps which are signposted
  • Source: Dr Mark Salter, HPA

His "top tips" for surviving festivals include using condoms, drinking plenty of water from a safe source, wearing a hat and sunscreen, and washing hands thoroughly after using the toilet.

Dr Salter said: "Avoid doing anything to excess is the best way to protect your health if you are visiting a festival this year.

"My experience of providing health advice and assistance at festivals for over 20 years tells me that people generally end up being unwell due to the combination of too much alcohol, drugs, sex and less than ideal hygiene.

"It is inevitable when suddenly thousands of people crowd together at a rural site with no fixed toilet system or bathing facilities and lots of alcoholic drinks that some people will become unwell as the risk of infection increases.

"It is therefore essential to follow good hygiene practices and wash your hands thoroughly after using the toilets."

More on This Story

Related Stories

The BBC is not responsible for the content of external Internet sites

Tuesday 15 March 2011

European hospitals asked be on standby for Japan's ill

European hospitals asked be on standby for Japan's ill

Red Cross worker being checked for radiation exposure Workers in the area are checked for radiation exposure

Five hundred bone marrow transplant centres across Europe are being asked to be on standby to treat Japanese radiation victims if the need arises.

The European Group for Blood and Marrow Transplantation (EBMT) has alerting its members, which include 3,000 medics in specialist units.

It is unclear how many in Japan might need their help, but the centres have plans and protocols ready to action.

Many were drawn up after the 11 September 2001 terror attacks.

It will be up to each centre to decide whether or not to take on any patients. In the UK there are 55 centres that could potentially help.

The president of the EBMT, Professor Alejandro Madrigal, said: "We are asking centres to tell us their level of response and capacity so we can measure the level of commitment at centres."

Professor Ray Powles, chair of the nuclear accident committee for EBMT, said it may be that between 20 and 30 workers at the nuclear Fukushima plant who are striving to contain the radiation will need treatment.

"It is too early to tell yet, but it is better to be prepared.

"If there was a humanitarian reason it would be something that could be offered.

"We have contacted Japan directly and have also offered our services to them through the World Health Organization.

"It's a logistic exercise.

"We have had training sessions and have a consensus on how to treat people who have been exposed to radiation.

"If workers have been exposed to harmful levels of radiation then we have a few days before they will get ill to plan their treatment.

"They might just need antibiotics or they might need antibiotics and other drugs as well as blood and platelets. It's not that dissimilar to treating leukaemia."

The treatment would largely be supportive care to manage the damaging effects of the radiation exposure. A few may require bone marrow transplants.

Professor Powles stressed that these patients would not pose any radiation risk to others around them.

More on This Story

From other news sites

* May require registration or subscription

The BBC is not responsible for the content of external Internet sites

Tuesday 22 February 2011

A watch-like device “could revolutionise blood pressure monitoring

Blood pressure device performs well


Monday February 21 2011

undefined

Wrist-worn blood pressure monitors are not new

A watch-like device “could revolutionise blood pressure monitoring”, BBC News has reported. According to the website, the monitor can be used to measure pressure in the wrist, which can then be used to estimate pressure in the aorta, the largest artery in the body.

Although news coverage has focussed on the wrist-worn monitor, the research devised a technique to combine blood pressure readings from the wrist and upper-arm to estimate central aortic systolic pressure (CASP). This measure of pressure in the aorta is thought to be a better way of predicting heart problems than traditional measures of blood pressure, such as using an inflatable cuff around the bicep.

A device to measure blood pressure at the wrist is not new, and the method does not replace the traditional approach of using a cuff on the upper arm. However, the researchers’ method for combining the two results to estimate CASP appears to have some merit, and may filter into medical care.

Where did the story come from?

The study was carried out by researchers from the University of Leicester, the National Institute for Health Research, Gleneagles Medical Centre in Singapore and Healthstats International in Singapore. The study was financially supported by the Leicester National Institute for Health Research Biomedical Research Unit in Cardiovascular Diseases. The study was published in the peer-reviewed Journal of the American College of Cardiology.

What kind of research was this?

Blood pressure has been measured through a blood vessel in the upper arm – the brachial artery – for many years. However, there is a current debate about whether the blood pressure measured in the arm accurately represents the corresponding pressure in the aorta, the large blood vessel that carries oxygenated blood away from the heart. Recent evidence suggests that central aortic systolic pressure (CASP), the pressure exerted as blood is pumped out of the heart and into the aorta, is a better predictor of structural damage to the heart and blood vessels.

In this study, researchers tested a mathematical algorithm to determine whether it could accurately estimate CASP using measurements of pressure in the radial artery at the wrist. The brachial artery in the upper arm divides at around the elbow, and the radial artery is one of the main branches of this, supplying blood to the forearm, wrist and hand.

The best way to measure CASP is to insert a pressure sensor into the aorta, but this is invasive and is usually only done when people undergo a procedure known as cardiac catheterisation. The procedure involves making an incision into the groin or upper arm to gain access to the arterial system, then feeding a guide wire and sheath through the arterial system so that a tiny pressure sensor can be positioned into the aorta or heart.

There are other ways to estimate CASP, such as reading the pressure in the radial artery and applying mathematical functions, called generalised transfer functions. Although this method is widely used, the application of generalised transfer functions has been criticised. In this study, researchers explored a different mathematical model to estimate CASP from the radial pressure.

This study had three separate parts, each involving a different group of participants. In the first, the researchers tested some key mathematical properties of their model. In the second, they compared their new way of estimating CASP with a well-known, accepted mathematical method. In the final part, they compared their non-invasive estimates of CASP with measures taken with cardiac catheterisation in people undergoing surgery.

What did the research involve?

The researchers tested the application of a mathematical approach called the n-point moving average. This is commonly used in other fields of study to help filter data and find underlying trends.

With each beat the heart contracts and relaxes, resulting in fluctuations in blood pressure over short periods of time. In their first experiment the researchers needed to determine how many tiny measurements of radial pressure their model would need to make within the cycle of a heartbeat. They enrolled 217 volunteers to help with this aspect of their model development.

In the second study, they used blood pressure readings taken as part of a large study that ran in Leicester over the course of five years. From this, they had 5,349 individual blood pressure readings to validate their new approach to calculating the central aortic pressure.

The final part of the experiment included 20 adults undergoing routine diagnostic cardiac catheterisation at the Gleneagles Medical Centre in Singapore. Their CASP was measured near the aortic valve directly in the heart. At the same time, a device was attached to their wrists to measure the radial pressure and a device was placed over the bicep of the same arm to measure the brachial pressure. The researchers were able to compare the measures of CASP from their model with the direct CASP measures in real time for up to three minutes.

What were the basic results?

The researchers determined the best structure for their model in the first group of volunteers. This structure led to estimates of CASP that closely approximated those derived through the more standard CASP estimation models. The accuracy of their estimates was not affected by age, gender, presence of diabetes or hypertension treatment in the participants.

In the invasive blood pressure experiment, brachial blood pressure (the standard measure in the upper arm) overestimated blood pressure compared to direct measurement of pressure in the aorta. There was strong correlation and agreement between direct measures of CASP and those estimated by the researchers’ mathematical model.

How did the researchers interpret the results?

The researchers concluded that their study demonstrates that a “simple moving average method” can be applied to brachial blood pressure measured across the wrist to estimate CASP.

Conclusion

This complex study involved the application of mathematical approaches to derive a measure of CASP from both radial artery pressure and brachial artery pressure. The researchers have developed a mathematical algorithm that appears to accurately predict CASP.

In commenting that a sensor strapped to the wrist that can “measure the pressure in the aorta”, The Independent misunderstood the mechanics of measures of radial pressure. The researchers measured pressure at both the wrist and at the upper arm and use mathematical approaches to convert them into an estimate of the pressure in the aorta.

The HealthSTATS sensor mentioned in news coverage is certainly not the first device of its kind, and there are several monitors which can be strapped to the wrist to measure radial pressure. However, it seems that the study’s technique of combining it with a traditional upper-arm cuff readings to create an estimate of CASP has some merit. The researchers make it very clear that this technology does not replace the traditional inflatable cuff, and that both methods are needed.

Past research suggests that CASP is a better marker of cardiovascular problems than upper-arm blood pressure readings. As such, more accurate measures of it, such as that allowed through this new approach, are likely to play a growing role in clinical practice

Blood pressure ! Millions 'misdiagnosed by GPs'

Patients will be sent home to test blood pressure as millions 'misdiagnosed by GPs'

One in four under 40s give a misleadingly high reading due to 'white coat nerves'

One in four under 40s give a misleadingly high reading due to 'white coat nerves'

Patients suspected of having high blood pressure will be sent home to test themselves for an extra 24 hours to make sure they were not misdiagnosed in the doctor’s surgery.

The additional tests follow concerns that some are being wrongly diagnosed because their blood pressure rises in the surgery - so-called ‘waiting room nerves’.

Currently, anyone suspected of having high blood pressure is diagnosed by a GP with an inflatable arm cuff.

They then have additional readings, but always at their surgery or in hospital.

Under new draft guidelines, which are open to consultation, the National Institute for Health and Clinical Excellence proposes doctors do not rely solely on readings taken in their surgeries.

Instead, after the initial assessment a patient should be sent home and asked to wear an ambulatory blood pressure monitoring, or ABPM, device.

This is an inflated arm cuff which takes spot readings over a 24-hour period. Around eight million people in Britain are currently diagnosed with high blood pressure, and at least six million are on drug treatment, with the majority aged 50 and over.

But experts say that up to a quarter of those under 40 are misdiagnosed because they develop ‘white coat hypertension’ in which their blood pressure gives a misleadingly high score because they are nervous.

The new guidelines will not change the threshold for treatment but provide an additional check to make sure no-one is incorrectly labelled as having high blood pressure.

In 2008, 32 per cent of men and 29 per cent of women in England had high blood pressure – defined as a systolic blood pressure of 140mmHg or over, or a diastolic blood pressure of 90mmHg or over – or were being treated for the condition.

Under the Nice guidelines, if blood pressure measurements taken during a consultation are 140/90mmHg or higher, then extra confirmation should be obtained over 24 hours at home.

Bryan Williams, professor of medicine at the University of Leicester, led the development of the guidelines.

He said doctors currently have to bring patients back to the clinic twice or more to get an accurate reading.

‘As many as 25 per cent of young people might record having high blood pressure when they go to the doctor when they actually don’t have it,’ he added.

‘When you are older, you are more likely to be hypertensive but, if you are at the margins and particularly if you are younger, then there’s a big error rate with diagnosis.

‘Evidence shows that if you used ambulatory testing before you treat, you would get the correct diagnosis more often.’

He said the guidance was not just cost-effective, but was cost-saving in the long run as less cash is spent on treatments.

He added: ‘What we want to do is ensure that the treatment goes to those people who need it



Read more: http://www.dailymail.co.uk/health/article-1359408/Patients-sent-home-test-blood-pressure.html#ixzz1EfwXZTGO

Wednesday 16 February 2011

Zinc can be an 'effective treatment' for common colds

Zinc can be an 'effective treatment' for common colds

Man sneezing Common cold viruses are spread by sneezes

Related Stories

Taking zinc syrup, tablets or lozenges can lessen the severity and duration of the common cold, experts believe.

A review of the available scientific evidence suggests taking zinc within a day of the onset of cold symptoms speeds recovery.

It may also help ward off colds, say the authors of the Cochrane Systematic Review that included data from 15 trials involving 1,360 people.

But they say zinc cannot be used long-term because of toxicity concerns.

Excessive amounts can cause nausea, vomiting, abdominal pain and diarrhoea.

Now more work is needed to determine the exact dosing required, say the experts.

Cold viruses

Adults catch between two to four colds a year and children up to 10 a year.

There is little a person can do to avoid these infections because the viruses responsible are so commonplace.

Start Quote

This review strengthens the evidence for zinc as a treatment for the common cold”

End Quote The review authors

Cold viruses can be passed from person to person not only by coughs and sneezes but also by touching contaminated surfaces such as door handles.

There is no proven treatment for the common cold, but experts believe zinc medications may help prevent and lessen infections by coating the common cold viruses and stopping them from entering the body through the thin lining of the nose.

It also appears to stop the virus from replicating, at least in laboratory tests.

There is also the suggestion that zinc aids the immune system and may dampen down some of the unpleasant reactions the body has to an invading virus.

Speedy recovery

Lead researcher Meenu Singh, of the Post Graduate Institute of Medical Education and Research in Chandigarh, India, said: "This review strengthens the evidence for zinc as a treatment for the common cold.

"However, at the moment, it is still difficult to make a general recommendation, because we do not know very much about the optimum dose, formulation or length of treatment."

According to trial results, zinc syrup, lozenges or tablets taken within a day of the onset of cold symptoms reduce the severity and length of illness.

At seven days, more of the patients who took zinc remedies every couple of hours during the daytime had cleared their symptoms compared to those who took placebos.

And children who took 15mg of zinc syrup or zinc lozenges daily for five months or longer caught fewer colds and took less time off school.

But the 15 trials in the review all used different treatment timescales and doses, making it impossible to reach a consensus.

And the people who used zinc also reported more side effects, such as an unpleasant aftertaste or nausea, than the placebo group.

Editor in Chief of the Cochrane Library, David Tovey, said: "This is a treatment that is showing some promise which, where treating the common cold is concerned, is unusual.

"Although there are many over-the-counter cold remedies already available, we are not awash with things that can stop cold symptoms or greatly reduce their severity.

"But there is still uncertainty about the best doses, timings and formulations and more studies will be needed to look at this."

Professor Ronald Eccles, Director of the Common Cold Centre at Cardiff University, remained doubtful about zinc's benefits as a cold treatment in current formulations.

He said zinc's toxicity would also be a potential concern if taken over longer periods.

More on This Story

Related Stories

From other news sites

* May require registration or subscription

The BBC is not responsible for the content of external Internet sites

Tuesday 15 February 2011

NHS 'failing to treat elderly with care and respect'

NHS 'failing to treat elderly with care and respect'

Elderly patient The elderly population is set to double over the next 25 years

Related Stories

The NHS is failing to treat elderly patients in England with care, dignity and respect, an official report says.

The Health Service Ombudsman came to the conclusion after carrying out an in-depth review of 10 cases.

The ombudsman, which deals with serious complaints against the NHS, said the patients - aged over 65 - suffered unnecessary pain, neglect and distress.

Charities said the findings were "sickening", while the government admitted improvement was needed.

While the report is only based on 10 cases, the ombudsman said they were far from isolated examples.

Of nearly 9,000 complaints made to the ombudsman last year, 18% were about the care of older people. In total, it accepted 226 cases for investigation - twice as many as for all the other age groups combined.

Ageing population

The report concluded there was a gulf between the principles and values of the NHS and the reality being experienced by older patients.

And the ombudsman, which is called in once a complaint cannot be resolved by individual NHS trusts, said the fact there was an ageing population made it even more essential that the concerns were dealt with.

Several themes became clear from the ombudsman's analysis. Half the people featured did not consume adequate food or water during their time in hospital.

Case study

After being admitted to hospital with severe abdominal and back pains, Mr D was diagnosed with advanced stomach cancer.

He asked to be discharged so he could die at home. But when his daughter arrived to collect him, she found him sitting behind a closed curtain in distress.

He had been left for several hours, was in pain, desperate to go to the toilet and unable to ask for help because he was so dehydrated that he could not speak or swallow.

The emergency button had been placed out of his reach, his drip had been removed, fallen and had leaked all over the floor.

At home, his family discovered Mr D had not been given the right pain relief.

His daughter said later: "It was as if he didn't exist." After investigating the case, the ombudsman found the trust had failed on a number of grounds.

Some were left in soiled or dirty clothes. One woman told the ombudsman how her aunt was taken on a long journey to a care home by ambulance.

She arrived strapped to a stretcher and soaked with urine, dressed in unfamiliar clothing held up by paper clips, accompanied by bags of dirty laundry, much of which was not her own.

Communication was also highlighted as a problem with one 82-year-old woman recalling how, on being discharged from hospital after minor surgery, she was frightened and unsure of how to get home.

She asked the nurse to phone her daughter, but was told "this is not my job".

In another case, a cancer patient wanted to be discharged to die at home. When his daughter arrived to collect him, she found him sitting behind a closed curtain in distress.

He had been left for several hours in pain and desperate to go to the toilet. He was unable to ask for help because he was so dehydrated that he could not speak or swallow.

'Harrowing'

Ann Abraham, the Health Service Ombudsman, said the accounts painted a picture of NHS provision that was "failing to meet even the most basic standards of care".

"These often harrowing accounts should cause every member of staff who reads this report to pause and ask themselves if any of their patients could suffer in the same way."

Michelle Mitchell, of Age UK, said: "The inhumane treatment of older people described in this report is sickening and should send shockwaves through the NHS and government."

And Katherine Murphy, chief executive of the Patients Association, added the report echoed the findings of research her group had done.

"How many reports do we have to have before anything will change and patients will stop suffering?"

Nigel Edwards, chief executive of the NHS Confederation, which represents NHS trusts, said the cases highlighted were "completely unacceptable".

But he added: "It is of course important to put these 10 examples in perspective. The NHS sees over a million people every 36 hours and the overwhelming majority say they receive good care."

Care services minister Paul Burstow agreed, but acknowledged standards still needed to improve.

"We need a culture where poor practice is challenged and quality is the watchword. The dignity of frail older people should never be sidelined."

He said the government's reforms of the NHS would strengthen the voice of patients.

Have you or your family been affected by any of the issues raised in this article? Send us your comments and experiences using the form below.

More on This Story

Related Stories

The BBC is not responsible for the content of external Internet sites

Thursday 10 February 2011

Swine flu narcolepsy 'link' probed by WHO

H1N1 virus More than 30 million doses of swine flu vaccine have been given in Europe

Related Stories

At least 12 countries have reported a possible link between a swine flu jab and a rare sleeping disorder, the World Health Organization has confirmed.

It said "further investigation was warranted" following reports of 52 cases of narcolepsy linked to the Pandemrix jab in Finland.

Cases have also been reported in Sweden, Iceland and the UK.

The government agency which regulates medicines in the UK said a link had not been confirmed.

The Medicines and Healthcare products Regulatory Agency (MHRA) said: "The Pandemrix vaccine remains available and should continue to be used as recommended.

"The benefits of vaccination outweigh any risk of a possible side effect."

Narcolepsy is a rare condition where a person falls asleep suddenly and unexpectedly.

A possible connection between the swine flu vaccine and the illness first came to light in Finland.

Finland and other Scandinavian countries have reported a general rise in cases of narcolepsy - in both vaccinated and unvaccinated people - but the cause has not been established.

UK cases

A recent investigation by Finnish authorities found children given the swine flu jab Pandemrix were about nine times more likely to develop narcolepsy than those who had not been vaccinated.

The WHO's global advisory committee on vaccine safety reviewed this, and other data, last week.

Narcolepsy

  • Narcolepsy is a rare illness, with around 10 new cases per million people every year
  • The main symptom is falling asleep suddenly
  • The cause of narcolepsy remains unclear
  • Some people may be predisposed to the condition by their genetics
  • Suggested initial triggers include infections such as measles or mumps, accidents and the hormonal changes that take place in puberty
  • It most often begins between the ages of 15 and 30

It said the committee would continue to monitor the situation and agrees that "further investigation is warranted concerning narcolepsy and vaccination against influenza (H1N1) 2009 with Pandemrix and other pandemic H1N1 vaccines".

The WHO said an increased risk of narcolepsy had not been observed with any other vaccines - for flu or other diseases - in the past.

It said: "Even at this stage, it does not appear that narcolepsy following vaccination against pandemic influenza is a general worldwide phenomenon and this complicates interpretation of the findings in Finland."

The Pandemrix vaccine, made by Glaxo Smith Kline, has been used in 47 countries following the swine flu outbreak last year.

More than six million doses of the H1N1 vaccine have been given in the UK, with more than 30 million given across Europe.

The MHRA said it had received four unconfirmed reports of narcolepsy following vaccination.

It said the reports so far in the UK "are no more than we would expect to see by coincidence after vaccination".

More on This Story

Related Stories

The BBC is not responsible for the content of external Internet sites

Saturday 5 February 2011

Brain scan of a patient with variant CJD

Blood test for vCJD 'could identify carriers'


MRI of CJD brain scan Brain scan of a patient with variant CJD, the yellow areas are diseased


Related Stories

A blood test for variant CJD has been developed by British scientists.
Currently patients suspected of having the human form of BSE have to undergo a series of tests, including a brain biopsy, to confirm a diagnosis.
The new test, reported in The Lancet, offers the chance of earlier diagnosis and potentially the ability to screen donor blood.
But further studies are needed before it can be widely used to screen healthy people who may be silent carriers.
Variant CJD or vCJD is the human form of BSE - "mad cow" disease. It affects the brain and is believed to have passed from cattle to humans through infected food.
There have been 170 confirmed deaths from vCJD in the UK, but a previous study suggested one in 4,000 Britons could be incubating the incurable degenerative disorder without symptoms.
CJD causes the brain to develop a spongy texture known as spongiform encephalopathy.
Early symptoms include anxiety, depression and tingling pains. Doctors often do not realise that a patient has the brain condition until other features occur, such as difficulty with movement, or loss of mental abilities.
At present, there is no treatment for variant CJD and the diagnosis is often made when patients are terminally ill.
The new test was tried on 190 blood samples, of which 21 had variant CJD. The test picked up 15 of the samples with variant CJD - a 71% success rate.
It did not produce any "false positives" - showing that someone had CJD, when they did not.
Early diagnosis
Professor John Collinge of the Medical Research Council is one of the doctors involved in the research. He said that he would begin using the new test on patients in his clinic straight away.
He said: "An earlier diagnosis will give patients and their families more time to plan what they would like to do in the time left available to them."

“Start Quote

This lifts us into the next stage and takes us to a position of hope”
End Quote Peter Mills Father of vCJD patient
Professor Collinge is currently working on research to treat the disease with antibodies.
He told the BBC that the first clinical studies involving patients could be carried out as early as next year.
A test that provides an early diagnosis will become even more significant if treatments for the disease become available.
The development was welcomed by Peter Mills, whose daughter Holly was diagnosed with variant CJD in 2003.
He described the test as milestone, saying: "This lifts us into the next stage and takes us to a position of hope. It gives us great confidence that therapies to treat the disease are a realistic prospect - but this test has to come first."
Silent carriers
The new test could provide more information on how many people have variant CJD and be used to screen for the disease.
However, further large scale studies on populations where the disease is not present would be needed before it could be used as a screening test.
The lead author of the research, Dr Graham Jackson of the Medical Research Council's Prion Unit, said: "This test could potentially go on to allow blood services to screen the population for vCJD infection, assess how many people in the UK are silent carriers and prevent onward transmission of the disease."
Patients and their families can find out more about the new development by looking at the National Prion Clinic website.
Chris James, from the Haemophilia Society said they would push for the test to be used as soon as it is clinically available: "The Haemophilia Society has long called for tests to be offered, in combination with pre and post-test counselling, to people with bleeding disorders who have been told they are at risk for public health purposes in relation to vCJD."

More on This Story

Related Stories


The BBC is not responsible for the content of external Internet sites

Thursday 6 January 2011

584 pregnancies despite contraceptive implant Implanon

584 pregnancies despite contraceptive implant Implanon

Implanon Implanon was first available in the UK in 1999

Related stories

Nearly 600 women have become pregnant despite using a popular contraceptive implant, a health watchdog has said.

There have also been more than 1,600 reports of adverse reactions to the Implanon device, which is designed to prevent pregnancy for three years.

The NHS has been forced to pay compensation to several women because of the failures, Channel 4 News reported.

The implant maker, MSD, said no contraceptive was 100% effective.

It added that unwanted pregnancies may occur if the implant was not correctly inserted, and said it had a failure rate of less than 1% if inserted correctly.

Safety review

The Medicines and Healthcare Regulatory Agency said that since the launch of Implanon in the UK 11 years ago, 584 women using it had become pregnant, with 1,607 reports of adverse reactions.

According to the Department of Health around 1.4 million women have used Implanon since it was first licenced in 1999.

The implant is a small plastic rod which releases hormones into the bloodstream, and is inserted under the skin of a woman's arm by a nurse or doctor.

The MHRA said it had also received complaints from doctors and nurses about difficulties inserting the device.

Start Quote

Implants are an excellent and usually extremely reliable method of birth control. But all contraceptives have a failure rate, and although with implants this is tiny, women do need to be aware”

End Quote Ann Furedi British Pregnancy Advisory Service

Late last year Implanon was replaced with a device called Nexplanon, which is designed to be inserted more easily.

The MHRA says although the implant had been replaced, "the safety of Implanon remains under close review."

Nine of the 584 women who reported an unwanted pregnancy used the terms "device failure", "device dislocation", "device ineffective" and "device difficult to use" to describe their experience.

Others reported scarring and problems with removing the 40mm long implant.

Correct insertion

A lawyer for some of the 14 women claiming for personal loss and damage said many had not realised the pre-loaded applicator had not released the implant.

Stephanie Prior, partner of Anthony Gold Solicitors, told Channel 4 News: "I have clients who fell pregnant as they were unaware that the Implanon device had not been inserted into their arm and they suffered psychological difficulties as a consequence of falling pregnant and later miscarrying or having to make the difficult decision to terminate the pregnancy."

Compensation

The NHS has paid compensation to nine women who between them received £118,000.

In a statement, manufacturers MSD said: "The basis for successful use of Implanon is a correct and carefully performed subdermal insertion of the implant in accordance with the product instructions.

"If the implant is not inserted in accordance with the instructions and on the correct day, this may result in an unintended pregnancy. In addition, no contraceptive is 100% effective."

Correct insertion of the device could be an issue, according to the Faculty of Sexual and Reproductive Healthcare. Their vice-president, Dr Alyson Elliman said:

"With the older device, Implanon, there is a risk of non-insertion - when someone might think they have inserted it but in fact the implant is still sitting in the tube which then gets removed. But clinicians are also relying on women having accurate recall of their menstrual cycle, and whether they have already risked pregnancy during that cycle."

Ann Furedi, chief executive of the British Pregnancy Advisory Service, added: "Implants are an excellent and usually extremely reliable method of birth control. But all contraceptives have a failure rate, and although with implants this is tiny, women do need to be aware."

Advice from the British Pregnancy Advisory Service is that women should not panic, even if they have one of the old versions of Implanon. They said:

"As long as you can feel the device under your skin and you are within the three year time frame there is no reason to get it checked, and no reason to request the newer version. However if you cannot feel it, or if you are having any problems with it, do get it seen. An ultrasound or x-ray will quickly establish whether the device is there."

More on This Story

Related stories

The BBC is not responsible for the content of external Internet sites

Thursday 30 December 2010

GPs report flu cases rose again last week

GPs report flu cases rose again last week

Flu jab Officials are urging patients in high-risk groups to get immunised

Related stories

Flu cases have risen again in England and Wales, according to figures from GPs.

Levels of flu - including H1N1 swine flu - have gone up by almost 50% in the past week, says the Royal College of GPs.

The flu tally reached 124 per 100,000 people in the week to Christmas, up from 86 cases in the previous week.

Health officials in England define an epidemic as 200 cases per 100,000.

Wednesday's figures come amid political debate over the decision not to give all young children a flu jab this winter.

Labour has criticised the lack of protection for healthy under-fives, but the government says they were excluded on medical and not cost grounds.

The latest figures show the highest rates are in children aged under five - at 184 cases per 100,000.

Professor Steve Field, a former chairman of the Royal College of GPs, said there was no indication in the current expert advice that across-the-board vaccination of young children is necessary.

Click to play

Professor Steve Field, the former the chairman of the Royal College of GPs, said those children at risk should be vaccinated as soon as possible.

He told the BBC: "Looking at the evidence - looking at where we are in this early epidemic, there doesn't seem to be any indication.

"But we do need to do better in those children who have asthma, who've got heart disease or other diseases and particularly pregnant women.

"I'm worried about the number of sick pregnant women who haven't been vaccinated. And we can prevent this illness by vaccination, which is safe."

The latest figures give an indication of the extent of this winter's flu outbreak, based on people visiting GP surgeries in England and Wales with flu-like symptoms.

Flu rates per 100,000

Flu cases have risen steadily in England and Wales from 32.8 per 100,000 in week 49, to 85.8 in week 50, to 124.4 in week 51.

The latest figures for Scotland, released on 23 December, show a rate of GP consultations for flu of 45.8 per 100,000.

In Northern Ireland, the latest figures available - for week 50 - show an increase from 28.1 to 64.6 per 100,000.

New figures for flu cases in Scotland and Northern Ireland will be released on Thursday.

A Department of Health spokesperson said the figures for England and Wales were "in keeping with what we would expect during a winter flu season".

Flu advice

  • Symptoms of seasonal flu include sudden onset of fever, cough as well as sore throat, aching muscles and joints
  • Antivirals are drugs given to high risk patients who become ill with seasonal influenza
  • They are most effective if taken within 48 hours of onset and may help limit the impact of some symptoms and reduce the potential for serious complications
  • Source: Health Protection Agency

The spokesperson added: "But everyone can do their bit to help keep well - simple measures like washing your hands help stop flu spreading.

"The Chief Medical Officer has issued clear advice to get the seasonal flu jab if you are in a vulnerable group, particularly pregnant women and people with underlying health conditions, as well as those aged 65 and over."

The vaccine protects against H1N1, the same strain of flu behind last year's swine flu pandemic, and also protects against the H3N2 and B strains.

Meanwhile, managers at a hospital on Merseyside have suspended visiting until further notice to minimise the chances of visitors passing on colds and flu.

Restrictions apply to relatives of patients at Arrowe Park Hospital in Birkenhead, Wirral.

French 'epidemic'

A flu outbreak has also been reported in France.

French health experts said on Wednesday the country was officially in the grip of a flu epidemic, with 176,000 people sick, two of whom have died.

In the UK, 27 people have died from flu this season, of which nine were children. Among the fatalities, 24 had swine flu. Three suffered from another strain, flu type B.

According to the World Health Organisation, flu epidemics result globally in about three to five million cases of severe illness per year and 250,000-500,000 deaths.

More on This Story

Related stories

The BBC is not responsible for the content of external Internet sites

Friday 24 December 2010

Swine flu vaccine safety probed over link to rare sleep disorder

Swine flu vaccine safety probed over link to rare sleep disorder

The safety of a swine flu vaccine is to be investigated by European drugs regulators after it was linked to a rare condition that causes people to fall asleep suddenly.

An investigation has been launched after a swine flu vaccine was linked to a condition that causes people to fall asleep suddenly.
An investigation has been launched after a swine flu vaccine was linked to a condition that causes people to fall asleep suddenly. Photo: Getty Images

The investigation has been prompted after health officials in Finland announced they were suspending the vaccination programme there following reports of narcolepsy in people who had received the jab.

So far there have been 27 reports of suspected narcolepsy in people across Europe who had previously been vaccinated with Pandemrix, the H1N1 swine flu vaccine made by GlaxoSmithKline.

No cases have been reported in Britain.

In total more than 30m people in the European Union have been vaccinated with Pandemrix.

Narcolepsy is a rare condition and its causes are unknown. It can be dangerous if sufferers fall asleep while driving or operating machinery. It is thought there are 25,000 people with the condition in Britain but experts have estimated that 80 per cent of sufferers have not been diagnosed.

Once diagnosed with the condition, which is long-term and has no cure, people are not allowed to drive.

The investigation will examine if Pandemrix was the likely trigger for the condition or whether it was a coincidence.

Finland suspended its national vaccination programme on Tuesday after eight suspected cases of narcolepsy following administration of the jab. A further ten cases have been reported in Sweden, six in France, and one each in Germany and Norway.

The European Medicines Agency will now investigate if there is any link, including how many people would normally be expected to suffer narcolepsy so this 'background rate' can be compared to with the number of cases observed after vaccination.

The Agency is also liaising with the European Centre for Disease Prevention and Control, other drugs regulators and the World Health Organisation.

A spokesman for GlaxoSmithKline said: "Information surrounding the reported cases remains limited at the current time. GSK is conducting its own investigation in an effort to gather as much additional data as possible regarding the observed cases and is working closely with the regulatory authorities, including the European Medicines Agency (EMA)

"Global experience with previous large-scale immunisation programmes has shown that it is likely that a certain level of adverse events will be reported. The adverse events that are reported may be the result of underlying conditions, or new conditions that occur in temporal association with the vaccination, and some events may be related to the vaccine.

"Having reviewed the currently available data and information regarding the reported cases of narcolepsy, which remains limited at this time, as well as GSK’s own safety database, the Company has concluded that the currently available information is insufficient to assess the likelihood of a causal relationship between Pandemrix and narcolepsy."

Featured post

More patients in Scotland given antidepressants

More patients in Scotland given antidepressants 13 October 2015   From the section Scotland Image copyright Thinkstock Image ca...